Hepcidin, Serum Iron, and Transferrin Saturation in Full-Term and Premature Infants during the First Month of Life: A State-of-the-Art Review of Existing Evidence in Humans

Neonates regulate iron at birth and in early postnatal life. We reviewed literature from PubMed and Ovid Medline containing data on umbilical cord and venous blood concentrations of hepcidin and iron, and transferrin saturation (TSAT), in human neonates from 0 to 1 mo of age. Data from 59 studies we...

Descripción completa

Detalles Bibliográficos
Autores principales: Cross, James H, Prentice, Andrew M, Cerami, Carla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413980/
https://www.ncbi.nlm.nih.gov/pubmed/32793848
http://dx.doi.org/10.1093/cdn/nzaa104
_version_ 1783568892544679936
author Cross, James H
Prentice, Andrew M
Cerami, Carla
author_facet Cross, James H
Prentice, Andrew M
Cerami, Carla
author_sort Cross, James H
collection PubMed
description Neonates regulate iron at birth and in early postnatal life. We reviewed literature from PubMed and Ovid Medline containing data on umbilical cord and venous blood concentrations of hepcidin and iron, and transferrin saturation (TSAT), in human neonates from 0 to 1 mo of age. Data from 59 studies were used to create reference ranges for hepcidin, iron, and TSAT for full-term-birth (FTB) neonates over the first month of life. In FTB neonates, venous hepcidin increases 100% over the first month of life (to reach 61.1 ng/mL; 95% CI: 20.1, 102.0 ng/mL) compared with umbilical cord blood (29.7 ng/mL; 95% CI: 21.1, 38.3 ng/mL). Cord blood has a high concentration of serum iron (28.4 μmol/L; 95% CI: 26.0, 31.1 μmol/L) and levels of TSAT (51.7%; 95% CI: 46.5%, 56.9%). After a short-lived immediate postnatal hypoferremia, iron and TSAT rebounded to approximately half the levels in the cord by the end of the first month. There were insufficient data to formulate reference ranges for preterm neonates.
format Online
Article
Text
id pubmed-7413980
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-74139802020-08-12 Hepcidin, Serum Iron, and Transferrin Saturation in Full-Term and Premature Infants during the First Month of Life: A State-of-the-Art Review of Existing Evidence in Humans Cross, James H Prentice, Andrew M Cerami, Carla Curr Dev Nutr Review Neonates regulate iron at birth and in early postnatal life. We reviewed literature from PubMed and Ovid Medline containing data on umbilical cord and venous blood concentrations of hepcidin and iron, and transferrin saturation (TSAT), in human neonates from 0 to 1 mo of age. Data from 59 studies were used to create reference ranges for hepcidin, iron, and TSAT for full-term-birth (FTB) neonates over the first month of life. In FTB neonates, venous hepcidin increases 100% over the first month of life (to reach 61.1 ng/mL; 95% CI: 20.1, 102.0 ng/mL) compared with umbilical cord blood (29.7 ng/mL; 95% CI: 21.1, 38.3 ng/mL). Cord blood has a high concentration of serum iron (28.4 μmol/L; 95% CI: 26.0, 31.1 μmol/L) and levels of TSAT (51.7%; 95% CI: 46.5%, 56.9%). After a short-lived immediate postnatal hypoferremia, iron and TSAT rebounded to approximately half the levels in the cord by the end of the first month. There were insufficient data to formulate reference ranges for preterm neonates. Oxford University Press 2020-06-17 /pmc/articles/PMC7413980/ /pubmed/32793848 http://dx.doi.org/10.1093/cdn/nzaa104 Text en Copyright © The Author(s) on behalf of the American Society for Nutrition 2020. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Cross, James H
Prentice, Andrew M
Cerami, Carla
Hepcidin, Serum Iron, and Transferrin Saturation in Full-Term and Premature Infants during the First Month of Life: A State-of-the-Art Review of Existing Evidence in Humans
title Hepcidin, Serum Iron, and Transferrin Saturation in Full-Term and Premature Infants during the First Month of Life: A State-of-the-Art Review of Existing Evidence in Humans
title_full Hepcidin, Serum Iron, and Transferrin Saturation in Full-Term and Premature Infants during the First Month of Life: A State-of-the-Art Review of Existing Evidence in Humans
title_fullStr Hepcidin, Serum Iron, and Transferrin Saturation in Full-Term and Premature Infants during the First Month of Life: A State-of-the-Art Review of Existing Evidence in Humans
title_full_unstemmed Hepcidin, Serum Iron, and Transferrin Saturation in Full-Term and Premature Infants during the First Month of Life: A State-of-the-Art Review of Existing Evidence in Humans
title_short Hepcidin, Serum Iron, and Transferrin Saturation in Full-Term and Premature Infants during the First Month of Life: A State-of-the-Art Review of Existing Evidence in Humans
title_sort hepcidin, serum iron, and transferrin saturation in full-term and premature infants during the first month of life: a state-of-the-art review of existing evidence in humans
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413980/
https://www.ncbi.nlm.nih.gov/pubmed/32793848
http://dx.doi.org/10.1093/cdn/nzaa104
work_keys_str_mv AT crossjamesh hepcidinserumironandtransferrinsaturationinfulltermandprematureinfantsduringthefirstmonthoflifeastateoftheartreviewofexistingevidenceinhumans
AT prenticeandrewm hepcidinserumironandtransferrinsaturationinfulltermandprematureinfantsduringthefirstmonthoflifeastateoftheartreviewofexistingevidenceinhumans
AT ceramicarla hepcidinserumironandtransferrinsaturationinfulltermandprematureinfantsduringthefirstmonthoflifeastateoftheartreviewofexistingevidenceinhumans